1177.HK Stock Analysis
11
Uncovered
Sino Biopharmaceutical Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Market cap $B
7.74
Dividend yield
2.53 %
Shares outstanding
18 476.58 B
Website
http://www.sinobiopharm.com/Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. The company employs 25,552 full-time employees The company went IPO on 2003-12-08. The firm operates through three business segments. The Modernized Chinese Medicine and Chemical Medicine segment is engaged in the manufacture, sale and distribution of modernized Chinese medicine products and western medicine products. The Investment segment is principally engaged in the long term and short term investments. The Other segment is principally engaged in the related medical and hospital business.